Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Finished Goods (2016 - 2025)

Historic Finished Goods for CV Sciences (CVSI) over the last 12 years, with Q3 2025 value amounting to $1.3 million.

  • CV Sciences' Finished Goods rose 1039.52% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 1039.52%. This contributed to the annual value of $1.7 million for FY2024, which is 537.29% up from last year.
  • Latest data reveals that CV Sciences reported Finished Goods of $1.3 million as of Q3 2025, which was up 1039.52% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Finished Goods ranged from a high of $3.3 million in Q4 2021 and a low of $1.2 million during Q3 2024
  • Its 5-year average for Finished Goods is $2.0 million, with a median of $1.7 million in 2024.
  • As far as peak fluctuations go, CV Sciences' Finished Goods plummeted by 4027.15% in 2022, and later soared by 1340.94% in 2024.
  • CV Sciences' Finished Goods (Quarter) stood at $3.3 million in 2021, then plummeted by 40.27% to $2.0 million in 2022, then fell by 20.1% to $1.6 million in 2023, then rose by 5.37% to $1.7 million in 2024, then decreased by 22.92% to $1.3 million in 2025.
  • Its Finished Goods was $1.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.4 million in Q1 2025.